Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02556294 · ClinicalTrials.gov registry record · NA
Fostering Resilience to Psychosocial and HIV Risk in Indian MSM
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 608
- Enrollment target
NCT02556294: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02556294 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 608 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02556294, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 608 participants
- Enrollment target
Study Summary
India has the world's third largest HIV epidemic and men who have sex with men (MSM) are an identified high risk group. MSM in India face unique psychosocial stress underlying the context of HIV risk. To maximize the potential impact of an HIV prevention intervention, the purpose of this study is to test, in a two-arm randomized controlled efficacy trial, a behavioral intervention that addresses both psychosocial / contextual stress and reducing participant's risk for HIV.
Primary Outcome
Self-reported insertive or receptive anal sex without the use of a condom.
Interventions
- BEHAVIORAL Self-acceptance based intervention
- BEHAVIORAL HIV/STI counseling and testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-08 |
| Phase | NA |
What the finished NCT02556294 record still lists
NCT02556294 is an interventional study that assigns participants to a tested intervention. The registered 608 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 2 interventions - of which Self-acceptance based intervention is the first listed.
NCT02556294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02556294 about?
NCT02556294 is a clinical study titled "Fostering Resilience to Psychosocial and HIV Risk in Indian MSM". India has the world's third largest HIV epidemic and men who have sex with men (MSM) are an identified high risk group. MSM in India face unique psychosocial stress underlying the context of HIV risk. To maximize the potential impact of an HIV prevention intervention, the purpose of this study is to...
What is the current status of trial NCT02556294?
This trial is currently completed. It is a NA study. The enrollment target is 608 participants. The study started on 2015-06. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02556294?
The interventions under investigation include: Self-acceptance based intervention (BEHAVIORAL), HIV/STI counseling and testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02556294?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02556294's enrollment target sits among peer trials
608 162nd of 2000 higher than 1,839 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02064673 · 608 participants · Phase 3
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
- NCT06091202 · 608 participants · Phase 3
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
- NCT06098144 · 608 participants · Phase 4
Smoking Cessation Program in the Construction Sector
- NCT00823654 · 609 participants
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia